These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22825126)

  • 1. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation.
    Shi ZD; Qian XM; Liu CY; Han L; Zhang KL; Chen LY; Zhang JX; Pu PY; Yuan XB; Kang CS;
    CNS Neurosci Ther; 2013 Feb; 19(2):98-108. PubMed ID: 23230963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
    Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The temozolomide derivative 2T-P400 inhibits glioma growth via administration route of intravenous injection.
    Li R; Tang D; Zhang J; Wu J; Wang L; Dong J
    J Neurooncol; 2014 Jan; 116(1):25-30. PubMed ID: 24065569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
    Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.
    Liu XY; Zhang L; Wu J; Zhou L; Ren YJ; Yang WQ; Ming ZJ; Chen B; Wang J; Zhang Y; Yang JM
    PLoS One; 2013; 8(11):e81345. PubMed ID: 24303044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.
    Ulasov I; Thaci B; Sarvaiya P; Yi R; Guo D; Auffinger B; Pytel P; Zhang L; Kim CK; Borovjagin A; Dey M; Han Y; Baryshnikov AY; Lesniak MS
    Cancer Med; 2013 Aug; 2(4):457-67. PubMed ID: 24156018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G
    Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
    Fiveash JB; Gillespie GY; Oliver PG; Zhou T; Belenky ML; Buchsbaum DJ
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):507-16. PubMed ID: 18474311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.
    Gilbert CA; Daou MC; Moser RP; Ross AH
    Cancer Res; 2010 Sep; 70(17):6870-9. PubMed ID: 20736377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
    Cho HY; Wang W; Jhaveri N; Torres S; Tseng J; Leong MN; Lee DJ; Goldkorn A; Xu T; Petasis NA; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Mol Cancer Ther; 2012 Nov; 11(11):2462-72. PubMed ID: 22933703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
    Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
    BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
    Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.